Skip to content

A Study of Internet Delivered Parent Child Interaction Therapy

Feasibility of Internet Delivered Parent Child Interaction Therapy (AI I-PCIT) Real-Time Monitoring of Sleep and Behavior of Children 3-7 Years-Old Receiving Remote PCIT

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05725525
Acronym
AI I-PCIT
Enrollment
5
Registered
2023-02-13
Start date
2023-03-02
Completion date
2023-12-01
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disruptive Behavior

Keywords

Garmin Watch, Artificial Intelligence, PCIT, Telehealth, Technology, Decentralized Trial

Brief summary

The purpose of this study is to learn more about how feasible remote parent child interaction therapy (PCIT) is for children with disruptive behaviors and how to augment treatment with wearable devices.

Detailed description

Children with disruptive behaviors aged 3-7 will wear a Garmin watch throughout the course of the study (approximately 12 weeks). Artificial Intelligence (AI) will be applied to analyze the vitals provided by the watch to monitor for disruptive behavior. Parent and child will be enrolled in remote PCIT sessions throughout the course of the trial. This study will not require any in person visits, all materials will be mailed to the patients home or sent electronically. The study will analyze how the use of a wearable device throughout PCIT will help increase the benefit to both parent and child as measured by biometrics via Garmin and by questionnaires preformed throughout the trial.

Interventions

BEHAVIORALRemote PCIT augmented with wearable devices

Participants will be enrolled in remote PCIT and be asked to wear a Garmin watch throughout the course of the study in order to measure biometric fluctuations

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Masking description

All participants will receive the same interventions

Eligibility

Sex/Gender
ALL
Age
3 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

- Children (Aged 3-7): * Outpatients. * Able to provide developmentally appropriate informed assent, and legal guardians able to provide informed consent. * EBP Severity rated above the clinically significant range (≥120; T-score ≥ 60) (Eyberg Child Behavior Inventory- ECBI; Eyberg & Pincus, 1999). * Families approached for participation will be asked to commit to complete the treatment: * At least one primary caregiver and the identified child will have to be able to speak and understand English; * Must have the ability, technology, and internet access for remote therapy/research visits. Inclusion Criteria - Adults (Any age): * Agree to wear Garmin watch. * Able to provide informed consent. * Able to speak and understand English. * Has the ability, technology, and internet access for remote therapy/research visits.

Exclusion criteria

- Children: * Formal diagnosis of Severe Intellectual disability, Autistic Spectrum Disorder Level 3, or a psychotic disorder for the child. * Parents not consenting to the study. * Parents or child is not able to adhere to the study protocol. * A Child who is reasonable expected to be unable to tolerate wearing the Garmin device for at least 70% of the time during the day and night 70% of the days during the treatment (12 weeks). This is based on the principal investigator's discretion. * Unable to speak and understand English. * Refusal or withdrawal of consent, inability, or unwillingness to adhere to study procedures. * Children in foster care. * Does not have the ability, technology, and/or internet access for remote therapy/research visits. * Need for more intensive behavioral treatments such as ER visit for behavioral dyscontrol or hospitalization will not be exclusionary or exit criteria.

Design outcomes

Primary

MeasureTime frameDescription
How wearing a Garmin watch will help the remote PCIT clinical outcomesThrough study completion, approximately 2 yearsBiometrics from the Garmin watch will be analyzed through Fitabase: step count, activity intensity, calories, heartrate, and respirations. This data will be compared throughout the study to see if factors trend down by the end of the trial. This would indicate that the child's behaviors were calmer at the end of the therapy when compared to the beginning.
Number of participants able to wear the Garmin watch throughout remote PCITThrough study completion, approximately 2 yearsThe study will measure how often participants are wearing the device by monitoring two platforms that are paired with the watch: Fitabase and Ilumivu. These platforms inform the study team with wear time of the watch by the participant. A measurement of at least 70% of the time will be deemed feasible/acceptable for young patient's ability to wear the watch during therapy.
Evaluating parental acceptance of remote PCIT augmented with a Garmin deviceThrough study completion, approximately 2 yearsAt the end of therapy, the parent will receive an emailed survey asking about their opinions of the study technology and how it added to their child's therapy experience.

Secondary

MeasureTime frameDescription
Evaluating clinical improvement from remote PCIT in regards to sleepThrough study completion, approximately 2 yearsThe study will collect parental rating scale measures of their child's sleep (PSQ). These reports will be collected weekly and will be compared throughout the course of therapy to see if parental reports of sleep gets better (length of time child is in bed and sleeping increases by the end of therapy).
Evaluating clinical improvement from remote PCIT in regards to parental reports of behavior accuracy of indirect behavioral measures from wearable devices to parental ratingsThrough study completion, approximately 2 yearsThe study will collect weekly parental ratings of their child's behavior (ECBI). These reports will be compared throughout the course of therapy to see if reports of the child's behavior is getting better throughout therapy.
Evaluating measured sleep data throughout remote PCITThrough study completion, approximately 2 yearsThe Garmin device will measure sleep cycle data (deep sleep, light sleep, REM sleep and hours awake). This data will be analyzed throughout participation to see if overall sleep time and quality increases with the amount of time spent in therapy.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026